Published in Lab Business Week, September 4th, 2005
Mechanical heart valve sales represented 94% of total revenue while other products and services represented 6% of total revenue. There was no meaningful impact on revenue from foreign currency exchange. The net loss for the second quarter of 2005 was $3.1 million, or $0.10 per share, compared with a net loss of $3.4 million, or $0.12 per share, in the second quarter of 2004.
For the first 6 months...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week